ArticleNaunyn-Schmiedeberg's archives of pharmacology2009

Nitric oxide-releasing agent, LA419, reduces atherogenesis in apolipoprotein E-deficient mice.

Ricardo Carnicer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.